The definition of vision impairment by the Centers for Disease Control and Prevention (CDC) says a visually impaired person’s eyesight cannot be corrected to a “normal level”.
The University of North Carolina at Chapel Hill has received a grant worth nearly $1.6 million over four years from the Agency for Healthcare Research and Quality to help reduce vision problems in African-Americans caused by glaucoma.
Blindness is expected to become three times more prevalent across the globe within the next four decades, warn researchers. According to a study published in Lancet Global Health, an estimated 36 million cases of blindness in 2015 is set to rise to 115 million by 2050, if funding for treatment is not increased.
Research funded by the National Eye Institute aims to reverse progression of cataracts- the most common cause of blindness worldwide- or to prevent them from forming altogether.
In a new medical breakthrough, reported in the journal Ophthalmology, doctors have successfully implanted magnets within a patient’s eyes to correct a condition called “nystagmus” also called “dancing eyes”.
Wayne State University recently received a five-year, $1.925 million grant from the National Eye Institute of the National Institutes of Health to test the role of microRNAs (miRNAs) - a newly recognized level of gene expression regulation - in bacterial keratitis – an infection of the cornea caused by bacteria - as well as to identify new therapeutic targets and alternative treatment strategies.
Researchers from the University of Eastern Finland have discovered a likely cause for visual impairment and eventual loss of vision in the Finnish variant of Neuronal Ceroid Lipofuscinosis.
Researchers comparing leading treatment approaches for patients with severe uveitis have discovered that systemic therapy with oral corticosteroids and immunosuppression can preserve or improve vision in the long term better than regional implant therapy can.
May is Healthy Vision Month when the National Eye Institute encourages everyone to make eye health a priority. This message is especially important for women, who make up two-thirds of all people living with blindness or visual impairment from diseases such as age-related macular degeneration, glaucoma, and cataract.
Since 2007, the World Health Organization (WHO) has been reporting outstanding success in dealing with neglected tropical diseases (NTDs) with 1 billion people estimated to have received treatments in 2015.
DGIST's research team has identified a mechanism that can recover the aging of patients with Hutchinson-Gilford Progeria Syndrome. DGIST announced that the Chair Professor Park SangChul of New Biology and the research team led by Professor Lee YoungSam has discovered a drug that can improve the aging of HGPS patients and identified the mechanism of aging recovery by using the drug.
Nearly 14 million Americans - about one out of every 20 people - have low vision, according to The Centers for Disease Control and Prevention. Eye-care professionals use the term "low vision" to describe significant visual impairment that cannot be corrected with standard glasses, contact lenses, medicine or eye surgery.
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.
New research reveals a high-resolution view of the Zika viral life cycle within infected cells and shows dramatic changes in the cell's architecture throughout the infection process. This novel perspective may lead to the development of new vaccines and treatments.
Multiple sclerosis (MS) clinicians face continued challenges in optimizing neurological care, especially for people with advanced MS living in medically underserved communities. Because of insurmountable geographical and physical challenges, patients cannot always travel to neurology office appointments.
Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.
During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.
The proportion of deaths attributable to diabetes in the U.S. is as high as 12 percent - three times higher than estimates based on death certificates suggest, according to a new analysis led by a Boston University School of Public Health researcher.
The UK’s current health and social care system isn’t fit for purpose when it comes to caring for people living with dementia (PLWD) who also have other illnesses and chronic conditions.
A mini-symposium published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus provides important insights into new techniques and treatments that show promise for eliminating retinopathy of prematurity (ROP) throughout the world.
VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration (FDA) approved the company's investigational device exemption for a new U.S. clinical study.